These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33481833)

  • 21. Impact of the gut-lung axis on tuberculosis susceptibility and progression.
    Enjeti A; Sathkumara HD; Kupz A
    Front Microbiol; 2023; 14():1209932. PubMed ID: 37485512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease.
    Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ
    J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. METABOLIC DYSBIOSIS OF THE GUT MICROBIOTA AND ITS BIOMARKERS.
    Sitkin SI; Tkachenko EI; Vakhitov TY
    Eksp Klin Gastroenterol; 2016 Jul; 12(12):6-29. PubMed ID: 29889418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Gut Microbiome in Pancreatic Disease.
    Akshintala VS; Talukdar R; Singh VK; Goggins M
    Clin Gastroenterol Hepatol; 2019 Jan; 17(2):290-295. PubMed ID: 30144522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wild mouse gut microbiota limits initial tuberculosis infection in BALB/c mice.
    Xie M; Tsai CY; McAdams ZL; Oo M; Hansen M; Dougher M; Sansano A; Watson A; LoMauro K; Antilus-Sainte R; Ericsson A; Dartois V; Gengenbacher M
    PLoS One; 2023; 18(7):e0288290. PubMed ID: 37494371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anaerobe-enriched gut microbiota predicts pro-inflammatory responses in pulmonary tuberculosis.
    Naidoo CC; Nyawo GR; Sulaiman I; Wu BG; Turner CT; Bu K; Palmer Z; Li Y; Reeve BWP; Moodley S; Jackson JG; Limberis J; Diacon AH; van Helden PD; Clemente JC; Warren RM; Noursadeghi M; Segal LN; Theron G
    EBioMedicine; 2021 May; 67():103374. PubMed ID: 33975252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastrointestinal microbiota composition predicts peripheral inflammatory state during treatment of human tuberculosis.
    Wipperman MF; Bhattarai SK; Vorkas CK; Maringati VS; Taur Y; Mathurin L; McAulay K; Vilbrun SC; Francois D; Bean J; Walsh KF; Nathan C; Fitzgerald DW; Glickman MS; Bucci V
    Nat Commun; 2021 Feb; 12(1):1141. PubMed ID: 33602926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute Sleep-Wake Cycle Shift Results in Community Alteration of Human Gut Microbiome.
    Liu Z; Wei ZY; Chen J; Chen K; Mao X; Liu Q; Sun Y; Zhang Z; Zhang Y; Dan Z; Tang J; Qin L; Chen JH; Liu X
    mSphere; 2020 Feb; 5(1):. PubMed ID: 32051239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjusting for age improves identification of gut microbiome alterations in multiple diseases.
    Ghosh TS; Das M; Jeffery IB; O'Toole PW
    Elife; 2020 Mar; 9():. PubMed ID: 32159510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Microbiome and Tuberculosis: Early Evidence for Cross Talk.
    Namasivayam S; Sher A; Glickman MS; Wipperman MF
    mBio; 2018 Sep; 9(5):. PubMed ID: 30228238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mycobacterium tuberculosis, antimicrobials, immunity, and lung-gut microbiota crosstalk: current updates and emerging advances.
    Osei Sekyere J; Maningi NE; Fourie PB
    Ann N Y Acad Sci; 2020 May; 1467(1):21-47. PubMed ID: 31989644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The gut microbiome alterations in allergic and inflammatory skin diseases - an update.
    Polkowska-Pruszyńska B; Gerkowicz A; Krasowska D
    J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):455-464. PubMed ID: 31520544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microbiome Changes during Tuberculosis and Antituberculous Therapy.
    Hong BY; Maulén NP; Adami AJ; Granados H; Balcells ME; Cervantes J
    Clin Microbiol Rev; 2016 Oct; 29(4):915-26. PubMed ID: 27608937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cross talk between dysbiosis and gut-associated immune system governs the development of inflammatory arthropathies.
    Kalinkovich A; Livshits G
    Semin Arthritis Rheum; 2019 Dec; 49(3):474-484. PubMed ID: 31208713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut microbiome and its role in cardiovascular diseases.
    Ahmadmehrabi S; Tang WHW
    Curr Opin Cardiol; 2017 Nov; 32(6):761-766. PubMed ID: 29023288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential Immunological Biomarkers for Detection of Mycobacterium tuberculosis Infection in a Setting Where M. tuberculosis Is Endemic, Ethiopia.
    Teklu T; Kwon K; Wondale B; HaileMariam M; Zewude A; Medhin G; Legesse M; Pieper R; Ameni G
    Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29311240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal profiling of gut microbiome among tuberculosis patients under anti-tuberculosis treatment in China: protocol of a prospective cohort study.
    Shi W; Hu Y; Zheng X; Ning Z; Wu M; Xia F; Prast-Nielsen S; Hu YOO; Xu B
    BMC Pulm Med; 2019 Nov; 19(1):211. PubMed ID: 31711450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Human Microbiome in the Fight Against Tuberculosis.
    Wood MR; Yu EA; Mehta S
    Am J Trop Med Hyg; 2017 Jun; 96(6):1274-1284. PubMed ID: 28719264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Faecalibacterium prausnitzii subspecies-level dysbiosis in the human gut microbiome underlying atopic dermatitis.
    Song H; Yoo Y; Hwang J; Na YC; Kim HS
    J Allergy Clin Immunol; 2016 Mar; 137(3):852-60. PubMed ID: 26431583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysbiosis of Gut Microbiota and Short-Chain Fatty Acids in Encephalitis: A Chinese Pilot Study.
    Xu R; Tan C; He Y; Wu Q; Wang H; Yin J
    Front Immunol; 2020; 11():1994. PubMed ID: 32973805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.